QS Investors LLC boosted its holdings in Nu Skin Enterprises, Inc. (NYSE:NUS) by 431.4% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 54,200 shares of the company’s stock after purchasing an additional 44,000 shares during the quarter. QS Investors LLC owned about 0.11% of Nu Skin Enterprises worth $3,071,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in NUS. Envestnet Asset Management Inc. boosted its holdings in Nu Skin Enterprises by 20.6% in the first quarter. Envestnet Asset Management Inc. now owns 7,287 shares of the company’s stock valued at $385,000 after purchasing an additional 1,246 shares in the last quarter. Russell Investments Group Ltd. lifted its stake in Nu Skin Enterprises by 84.5% in the first quarter. Russell Investments Group Ltd. now owns 101,811 shares of the company’s stock valued at $5,426,000 after buying an additional 46,625 shares during the last quarter. Rockefeller Capital Management L.P. lifted its stake in Nu Skin Enterprises by 19,862.5% in the first quarter. Rockefeller Capital Management L.P. now owns 1,597 shares of the company’s stock valued at $84,000 after buying an additional 1,589 shares during the last quarter. Teacher Retirement System of Texas lifted its stake in Nu Skin Enterprises by 21.0% in the first quarter. Teacher Retirement System of Texas now owns 5,935 shares of the company’s stock valued at $314,000 after buying an additional 1,031 shares during the last quarter. Finally, UBS Group AG lifted its stake in Nu Skin Enterprises by 41.0% in the first quarter. UBS Group AG now owns 41,399 shares of the company’s stock valued at $2,190,000 after buying an additional 12,038 shares during the last quarter. 81.06% of the stock is owned by hedge funds and other institutional investors.
NUS has been the subject of a number of research reports. TheStreet cut Nu Skin Enterprises from a “b-” rating to a “c+” rating in a research note on Friday, October 8th. DA Davidson reduced their price objective on Nu Skin Enterprises from $61.00 to $47.00 and set a “neutral” rating for the company in a research note on Wednesday, October 6th. Citigroup cut their price target on Nu Skin Enterprises from $59.00 to $43.00 and set a “neutral” rating for the company in a research note on Tuesday. Tigress Financial restated a “buy” rating and set a $72.00 price target on shares of Nu Skin Enterprises in a research note on Friday, October 1st. Finally, Zacks Investment Research cut Nu Skin Enterprises from a “buy” rating to a “sell” rating and set a $43.00 price target for the company. in a research note on Friday, October 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $55.83.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Wednesday, August 4th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.06 by $0.09. The firm had revenue of $704.10 million during the quarter, compared to analysts’ expectations of $703.38 million. Nu Skin Enterprises had a return on equity of 26.95% and a net margin of 8.35%. Nu Skin Enterprises’s revenue was up 15.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.81 earnings per share. On average, analysts predict that Nu Skin Enterprises, Inc. will post 4.42 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 8th. Shareholders of record on Friday, August 27th were given a $0.38 dividend. This represents a $1.52 annualized dividend and a yield of 3.73%. The ex-dividend date was Thursday, August 26th. Nu Skin Enterprises’s payout ratio is 41.87%.
In related news, SVP Jeffrey Clark Bettinger sold 1,625 shares of the stock in a transaction dated Tuesday, October 5th. The stock was sold at an average price of $41.10, for a total transaction of $66,787.50. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Joseph Y. Chang sold 16,000 shares of the stock in a transaction dated Monday, September 13th. The stock was sold at an average price of $47.41, for a total value of $758,560.00. Following the transaction, the executive vice president now owns 33,942 shares in the company, valued at $1,609,190.22. The disclosure for this sale can be found here. 4.00% of the stock is currently owned by corporate insiders.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes personal care products and nutritional supplements. The firm engages in the provision of beauty and wellness products and solutions. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J.
Featured Article: How does equity income fit into an investing strategy?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.